Anti-HGFA Inhibitor 2 antibody [EPR6283(2)],Abcam,AB128926
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human
Application
WB, ICC/IF
Platform ID
BAB892517117
Abcam
Contact
Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215
Email:
Product Specifications
Scientific Background
Specifications
NameAnti-HGFA Inhibitor 2 antibody [EPR6283(2)]
Cat. No.AB128926
HostRabbit
IsotypeIgG
ReactivityHuman
ApplicationWB, ICC/IF
ClonalityMonoclonal
Clone NumberEPR6283(2)
Concentration0.298 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Storage-20°C
Regulatory StatusResearch Use Only
Scientific Background
Target data Inhibitor of HGFAC (PubMed : 9346890). Also inhibits plasmin, and plasma and tissue kallikrein (PubMed : 9115294). Inhibits serine protease activity of TMPRSS13 (PubMed : 20977675, PubMed : 28710277). Inhibits serine protease activity of ST14/matriptase and PRSS8/prostasin in vitro (PubMed : 28710277, PubMed : 30445423). See full target information SPINT2
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
- Products>Primary Antibodies>Recombinant Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.